Companies Cryptocurrencies
Applied Molecular Transport Inc.
Applied Molecular Transport Inc.
Exchange: NasdaqGS
IPO Date: 05/06/2020
CEO: Dr. Tahir Mahmood Ph.D.
Biotechnology Healthcare đź”—
  • AMTI
  • 2.32
  • 89677744
    market cap
  • -0.79999995
If you bought

shares of Applied Molecular Transport Inc. (AMTI) on
You would have made
Old Price $12 Current Price $12

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. The Company is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The Company is building a portfolio of oral product candidates based on its technology platform including its product candidate, AMT-101, an oral GI-selective rhIL-10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). The Company’s other product candidate, AMT-126, is a GI-selective oral fusion of rhIL-22. The Company’s technology platform enables it to design and develop various oral biologic therapeutic modalities, such as peptides, proteins, full-length antibodies, antibody fragments, and ribonucleic acid (RNA) therapeutics, with development-stage drugs.

Address: 1 Tower Place Suite 850 South San Francisco CALIFORNIA 94080

Stay updated.